ASP8477: Clinical Trials

2 trials of ASP8477, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow ASP8477: new trials by email Literature Review of ASP8477 trials Research Report on ASP8477

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety
ASP8477, Placebo - Post-Herpetic Neuralgia (PHN), Neuropathic Pain
Phase 2CompletedAstellas Pharma Europe B.V.1322014-02-242017-11-08
A Study to Assess the Effects of Single Ascending Doses (SAD) of ASP8477, the Effect That Food Has on the Drug, and the Interaction Between ASP8477 and Omeprazole in Healthy Postmenopausal Females and Healthy Young Vasectomized Males
ASP8477, omeprazole, Placebo - Pharmacokinetics of ASP8477, Pharmacodynamics of ASP8477
Phase 1CompletedAstellas Pharma Europe B.V.722010-11-012014-08-20

Conditions studied

Metatropic dwarfism (1)  ·  Neuralgia (1)  ·  Neuralgia, Postherpetic (1)  ·  Pain (1)  ·  Peripheral Nervous System Diseases (1)

Sponsors

Astellas Pharma Europe B.V. (2)

Countries

Belgium (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Poland (1)  ·  United Kingdom (1)

NIH funding

2009 (1)